News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Peter Benton is president and CEO of Worldwide Clinical Trials, a full-service global CRO. We spoke with him about his insights into recent trends and factors influencing biopharma investment decisions.
Oxford BioDynamics, a biotech company specializing in precision medicine tests via the EpiSwitch 3D genomics platform, has partnered with the Goodbody Clinic, a provider of private health testing services.
Cartherics, a biotechnology company specializing in immune cell therapies for cancer, has announced the granting of its second European patent.